Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infections
Contributors
Harbarth, Stéphan JuergenPublished in
Evidence-based medicine, vol. 20, no. 4, 140Publication date
2015UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
HARBARTH, Stéphan Juergen. Trimethoprim-sulfamethoxazole monotherapy should not be used for treatment of severe methicillin-resistant Staphylococcus aureus infections. In: Evidence-based medicine, 2015, vol. 20, n° 4, p. 140. doi: 10.1136/ebmed-2015-110241
Main files (1)
Article (Published version)
Identifiers
- PID : unige:78231
- DOI : 10.1136/ebmed-2015-110241
- PMID : 26156632
